Patient D: Microdosing Ibogaine for Parkinson’s

Patient D: Microdosing Ibogaine for Parkinson’s

Interviewed by Lakshmi Narayan and Eric SwensonAt the time of this interview in 2019, Patient D was a 76-year old individual who was diagnosed with Parkinson’s five years before and was able to manage and improve his symptoms by microdosing ibogaine. He passed away in...

A Journey in Word 2 by Jack Cross

A Journey in Word 2 by Jack Cross

There is a holographic awakening to be had from the words and letters of the English/Latin alphabet and author and psychonaut Jack Cross un-spells the Way in Part 2 of his series “A Journey in Word. The video is a mesmerizing visual experience that will put you...

Addiction and the Core Wound with Deanne Adamson

Addiction and the Core Wound with Deanne Adamson

How does IBOGA work in a single treatment when traditional rehab and therapies fail? The answer is simple. It gets to the root cause. In the opinion of addiction expert Dr. Gabor Maté, who has worked with hundreds of addicts in the course of his practice, addiction is...

Healing the Heart of Addictive Mind with Iboga

Healing the Heart of Addictive Mind with Iboga

The heart of addictive mind is desire and attachment. The mind gets hijacked into the most pleasurable experiences, and all of a sudden the new, conditioned thought pattern is in place. What is Iboga? This is a legend about the discovery of iboga. Hundreds of years...

18-MC: the Synthetic Derivative of Ibogaine

18-MC: the Synthetic Derivative of Ibogaine

Stanley Glick, PhD, MD, shares his views on the past, present, and future of ibogaine and 18-MC and on the prejudice against addicts and psychedelic drugs that inhibits funding for medical research. Would you please give us a synopsis of the history of your research,...

×